Trial intelligence / Profile preview

Gemcitabine, Cisplatin, 5-FU, and Folinic Acid in Inoperable Esophageal Cancer

NCT00759226Phase 2Completed

Start
Jul 2002
Primary completion
Jul 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gemcitabine in esophageal cancer. Started Jul 2002; status: completed.

02

Drugs

gemcitabine
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT00759226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00759226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call